Allakos Inc. - Special Call Transcript
Good day, and welcome to the conference call hosted by Allakos. Today's conference is being recorded.
At this time, I would like to turn the conference over to Mr. Robert Alexander, CEO of Allakos. Please go ahead, sir.
Thank you. I'd like to thank everybody for joining our call today. Here with me in the room, I have Adam Tomasi, our CFO; Henrik Rasmussen, our Chief Medical Officer; and Drs. Foster and Anesi who are principal investigators for our conjunctivitis study.
Before we jump into the presentation, a reminder that we will be making forward-looking statements so please refer to our SEC filings for a discussion of risk factors.
Okay. On the next slide is the agenda for today. So I will be going over a little bit of background on AK002, and then I'll turn it over to Henrik to review our clinical programs to-date. And then we will turn it over to Drs. Foster and Anesi to run through the data from our conjunctivitis study. And following that, we'll go into a Q&A.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |